Malignant neoplasm of pancreas

Known as: boesartige Neubildung Pankreas, ONDARTET SVULST BUKSPYTTKJERTELEN, Cancer of the Pancreas 
A primary or metastatic malignant tumor involving the pancreas. Representative examples include carcinoma and lymphoma. -- 2003
National Institutes of Health

Related topics

Related topics

16 relations
Exocrine pancreasGastrointestinal carcinomaGastrointestinal systemLI-FRAUMENI SYNDROME 1
(More)

Broader (3)

Gastrointestinal NeoplasmsPancreasPancreatic Neoplasm

Narrower (2)

Pancreatic Endocrine Carcinomacarcinoma of head of pancreas

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways
The epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase that is commonly upregulated in cancers such as in non… (More)
  • figure 1
Is this relevant?
Review
2017
Review
2017
Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer.
Pancreatic ductal adenocarcinoma is on pace to become the second leading cause of cancer-related death. The high mortality rate… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Review
2016
Review
2016
Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiving Induction Chemotherapy and Consolidative Chemoradiation.
PURPOSE To review outcomes of locally advanced pancreatic cancer (LAPC) patients treated with dose-escalated intensity modulated… (More)
Is this relevant?
Review
2016
Review
2016
Oncogenic role of leptin and Notch interleukin-1 leptin crosstalk outcome in cancer.
Obesity is a global pandemic characterized by high levels of body fat (adiposity) and derived-cytokines (i.e., leptin). Research… (More)
  • figure 1
  • table 1
Is this relevant?
Highly Cited
2014
Highly Cited
2014
Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.
Cancer incidence and deaths in the United States were projected for the most common cancer types for the years 2020 and 2030… (More)
  • table 1
  • table 1
  • figure 1
  • table 2
  • table 2
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial.
PURPOSE The trial objectives were to identify the maximum-tolerated dose (MTD) of first-line gemcitabine plus nab-paclitaxel in… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses.
There are currently few therapeutic options for patients with pancreatic cancer, and new insights into the pathogenesis of this… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Review
2004
Review
2004
An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms.
Invasive pancreatic ductal adenocarcinoma is an almost uniformly fatal disease. Several distinct noninvasive precursor lesions… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma.
Regulatory T cells (T(reg)) that prevent autoimmune diseases by suppression of self-reactive T cells may also suppress the immune… (More)
  • table I
  • figure 1
  • figure 2
  • table II
  • figure 3
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
PURPOSE Most patients with advanced pancreas cancer experience pain and must limit their daily activities because of tumor… (More)
Is this relevant?